KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Cash from Operations (2018 - 2025)

Historic Cash from Operations for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to -$3.1 million.

  • ClearPoint Neuro's Cash from Operations fell 16030.03% to -$3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.1 million, marking a year-over-year decrease of 4801.71%. This contributed to the annual value of -$9.0 million for FY2024, which is 3440.23% up from last year.
  • As of Q3 2025, ClearPoint Neuro's Cash from Operations stood at -$3.1 million, which was down 16030.03% from -$2.5 million recorded in Q2 2025.
  • In the past 5 years, ClearPoint Neuro's Cash from Operations registered a high of -$1.2 million during Q4 2023, and its lowest value of -$6.2 million during Q1 2025.
  • In the last 5 years, ClearPoint Neuro's Cash from Operations had a median value of -$3.3 million in 2021 and averaged -$3.3 million.
  • As far as peak fluctuations go, ClearPoint Neuro's Cash from Operations surged by 6185.97% in 2023, and later plummeted by 16030.03% in 2025.
  • Quarter analysis of 5 years shows ClearPoint Neuro's Cash from Operations stood at -$3.6 million in 2021, then rose by 13.71% to -$3.1 million in 2022, then surged by 61.86% to -$1.2 million in 2023, then dropped by 10.61% to -$1.3 million in 2024, then crashed by 141.38% to -$3.1 million in 2025.
  • Its Cash from Operations stands at -$3.1 million for Q3 2025, versus -$2.5 million for Q2 2025 and -$6.2 million for Q1 2025.